Evidence map›Paper›PMID 34159625›Full record

ArticleJournal of gastroenterology and hepatology2021

Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer.

Xiaoling Gao, Rui Guo, Yonghong Li, Guolan Kang, Yu Wu, Jia Cheng, Jing Jia, Wanxia Wang, Zhenhao Li, Anqi Wang and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. The multifaceted roles of ribosomal P complex in cancer.World journal of surgical oncology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Xiaoling GaoNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-5466-3200
Rui GuoNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-5359-0994
Yonghong LiNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-5198-3786
Guolan KangDepartment of Endoscopic Diagnosis and Treatment Center, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-7579-3557
Yu WuNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0003-0205-6529
Jia ChengDepartment of Endoscopic Diagnosis and Treatment Center, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0001-9043-5398
Jing JiaNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-7254-7115
Wanxia WangNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-9008-6324
Zhenhao LiNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-8173-9450
Anqi WangNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-9798-985X
Hui XuThe Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0003-1237-7027
Yanjuan JiaThe Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0001-5896-3684
Yuanting LiThe Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0003-1398-3168
Xiaoming QiThe Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-9666-7701
Zhenhong WeiThe Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0001-8494-7610
Chaojun WeiNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-1769-7655
Gansu Provincial Hospital · CN

Funding

Natural Science Foundation of Gansu Province 20JR10RA401Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2019PT320005Research Project of Gansu Provincial Hospital 17GSSYT-10Research Project of Gansu Provincial Hospital 18GSSY5-24
6 · The paper itself

Abstract

BACKGROUND AND

aimMetabolic reprogramming is characterized by dysregulated levels of metabolites and metabolic enzymes. Integrated metabolomic and transcriptomic data analysis can help to elucidate changes in the levels of metabolites and metabolic enzymes, screen the core metabolic pathways, and develop novel therapeutic strategies for cancer.

methodsHere, the metabolome of gastric cancer tissues was determined using liquid chromatography-mass spectrometry. The transcriptome data from The Cancer Genome Atlas dataset were integrated with the liquid chromatography-mass spectrometry data to identify the common dysregulated gastric cancer-specific metabolic pathways. Additionally, the protein expression and clinical significance of key metabolic enzymes were examined using a gastric cancer tissue array.

resultsMetabolomic analysis of 16 gastric cancer tissues revealed that among the 15 dysregulated metabolomic pathways, the aminoacyl-tRNA biosynthesis pathway in the gastric tissues was markedly upregulated relative to that in the adjacent noncancerous tissues, which was consistent with the results of transcriptome analysis. Bioinformatic analysis revealed that among the key regulators in the aminoacyl-tRNA biosynthesis pathway, the expression levels of threonyl-tRNA synthetase (TARS) and phenylalanyl-tRNA synthetase (FARSB) were correlated with tumor grade and poor survival, respectively. Additionally, gastric tissue array data analysis indicated that TARS and FARSB were upregulated in gastric cancer tissues and were correlated with poor prognosis and tumor metastasis.

conclusionsThis study demonstrated that the aminoacyl-tRNA biosynthesis pathway is upregulated in gastric cancer and both TARS and FARSB play key roles in the progression of gastric cancer. Additionally, a novel therapeutic strategy for gastric cancer was proposed that involves targeting the aminoacyl-tRNA biosynthesis pathway.

Indexed as

Phenylalanine-tRNA LigaseStomach NeoplasmsThreonine-tRNA LigaseAmino Acyl-tRNA SynthetasesHumansMetabolomeRNA, TransferTranscriptomeUp-RegulationAmino Acyl-tRNA SynthetasesPhenylalanine-tRNA LigaseRNA, TransferThreonine-tRNA LigaseAminoacyl-tRNA biosynthesisGastric cancerIntegrated pathwayMetabolic pathwayTranscriptomics

Identifiers

PMID34159625
PMCPMC9292402
OpenAlexW3176672033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.